These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 34070853)

  • 1. Nuclear Imaging for the Diagnosis of Cardiac Amyloidosis in 2021.
    Li W; Uppal D; Wang YC; Xu X; Kokkinidis DG; Travin MI; Tauras JM
    Diagnostics (Basel); 2021 May; 11(6):. PubMed ID: 34070853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear Molecular Imaging of Disease Burden and Response to Treatment for Cardiac Amyloidosis.
    Zhao M; Calabretta R; Yu J; Binder P; Hu S; Hacker M; Li X
    Biology (Basel); 2022 Sep; 11(10):. PubMed ID: 36290299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of cardiac amyloidosis incidentally detected by bone scintigraphy.
    Tanaka H; Hosono M; Kanagaki M; Shimizu M; Matsubara N; Kawabata K; Miyamoto T; Itoi K
    Asia Ocean J Nucl Med Biol; 2021; 9(1):71-75. PubMed ID: 33392354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Nuclear Imaging in Cardiac Amyloidosis Management: Clinical Evidence and Review of Literature.
    Frantellizzi V; Cosma L; Pani A; Pontico M; Conte M; De Angelis C; De Vincentis G
    Curr Med Imaging; 2020; 16(8):957-966. PubMed ID: 33081658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques.
    Aljaroudi WA; Desai MY; Tang WH; Phelan D; Cerqueira MD; Jaber WA
    J Nucl Cardiol; 2014 Apr; 21(2):271-83. PubMed ID: 24347127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosing cardiac amyloidosis in every-day practice: A practical guide for the cardiologist.
    Papathanasiou M; Carpinteiro A; Rischpler C; Hagenacker T; Rassaf T; Luedike P
    Int J Cardiol Heart Vasc; 2020 Jun; 28():100519. PubMed ID: 32373710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac amyloidosis: An underdiagnosed/underappreciated disease.
    Manolis AS; Manolis AA; Manolis TA; Melita H
    Eur J Intern Med; 2019 Sep; 67():1-13. PubMed ID: 31375251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of nuclide scintigraphy in the diagnosis and prognosis of cardiac amyloidosis.
    Mo Q; Deng Z; Xiao Y; Liu C; Zhao M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 48(11):1739-1745. PubMed ID: 38432865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial Amyloidosis: The Exemplar Interstitial Disease.
    Fontana M; Ćorović A; Scully P; Moon JC
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2345-2356. PubMed ID: 31422120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radionuclide Imaging of Cardiac Amyloidosis.
    Joseph V; Julien HM; Bravo PE
    PET Clin; 2021 Apr; 16(2):285-293. PubMed ID: 33589384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in PET-Based Cardiac Amyloid Radiotracers.
    Gallegos C; Miller EJ
    Curr Cardiol Rep; 2020 May; 22(6):40. PubMed ID: 32430600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement.
    Rigopoulos AG; Ali M; Abate E; Torky AR; Matiakis M; Mammadov M; Melnyk H; Vogt A; de Vecchis R; Bigalke B; Wohlgemuth W; Mavrogeni S; Noutsias M
    Heart Fail Rev; 2019 Jul; 24(4):521-533. PubMed ID: 30790171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging of cardiac amyloidosis by (99m)Tc-PYP scintigraphy.
    Papantoniou V; Valsamaki P; Kastritis S; Tsiouris S; Delichas Z; Papantoniou Y; Tsiouma M; Athanasoulis T; Fotopoulos A; Dimopoulos MA
    Hell J Nucl Med; 2015; 18 Suppl 1():42-50. PubMed ID: 26665211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis.
    Fine NM; Davis MK; Anderson K; Delgado DH; Giraldeau G; Kitchlu A; Massie R; Narayan J; Swiggum E; Venner CP; Ducharme A; Galant NJ; Hahn C; Howlett JG; Mielniczuk L; Parent MC; Reece D; Royal V; Toma M; Virani SA; Zieroth S
    Can J Cardiol; 2020 Mar; 36(3):322-334. PubMed ID: 32145862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wild-Type Transthyretin Cardiac Amyloidosis: Novel Insights From Advanced Imaging.
    Narotsky DL; Castano A; Weinsaft JW; Bokhari S; Maurer MS
    Can J Cardiol; 2016 Sep; 32(9):1166.e1-1166.e10. PubMed ID: 27568874
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Kollikowski AM; Kahles F; Kintsler S; Hamada S; Reith S; Knüchel R; Röcken C; Mottaghy FM; Marx N; Burgmaier M
    Intractable Rare Dis Res; 2017 Nov; 6(4):291-294. PubMed ID: 29259858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis.
    Martini N; Rizzo S; Sarais C; Cipriani A
    BMC Cardiovasc Disord; 2020 Oct; 20(1):466. PubMed ID: 33121442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal Imaging and Biomarkers in Cardiac Amyloidosis.
    Jung MH; Chang S; Han EJ; Youn JC
    Diagnostics (Basel); 2022 Mar; 12(3):. PubMed ID: 35328180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid transthyretin cardiac amyloidosis: diagnosis and management.
    Di Giovanni B; Gustafson D; Delgado DH
    Expert Rev Cardiovasc Ther; 2019 Sep; 17(9):673-681. PubMed ID: 31478389
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.